Stephen Pianko

1.5k total citations
35 papers, 1.1k citations indexed

About

Stephen Pianko is a scholar working on Hepatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Stephen Pianko has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hepatology, 26 papers in Epidemiology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Stephen Pianko's work include Hepatitis C virus research (28 papers), Liver Disease Diagnosis and Treatment (17 papers) and Hepatitis B Virus Studies (15 papers). Stephen Pianko is often cited by papers focused on Hepatitis C virus research (28 papers), Liver Disease Diagnosis and Treatment (17 papers) and Hepatitis B Virus Studies (15 papers). Stephen Pianko collaborates with scholars based in Australia, United States and France. Stephen Pianko's co-authors include John G. McHutchison, Keyur Patel, William Sievert, Shane Patella, Paul J. Pockros, Alexander Thompson, Alexander Monto, Teresa L. Wright, G. Mani Subramanian and Alan Bostrom and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Stephen Pianko

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Pianko Australia 19 862 845 112 108 92 35 1.1k
Yi‐Hao Yen Taiwan 23 1.3k 1.5× 1.1k 1.3× 70 0.6× 137 1.3× 69 0.8× 126 1.6k
Eduardo B. Martins United States 17 1.0k 1.2× 1.1k 1.3× 37 0.3× 72 0.7× 133 1.4× 42 1.4k
Elisabetta Degasperi Italy 19 887 1.0× 918 1.1× 29 0.3× 102 0.9× 90 1.0× 82 1.2k
Jaime Enríquez Spain 11 693 0.8× 597 0.7× 66 0.6× 58 0.5× 95 1.0× 16 850
Claudio Zavaglia Italy 19 1.2k 1.4× 731 0.9× 176 1.6× 136 1.3× 39 0.4× 38 1.4k
Franklin H. Herlong United States 10 511 0.6× 449 0.5× 65 0.6× 72 0.7× 35 0.4× 10 692
Themistoklis Vassiliadis Greece 17 371 0.4× 427 0.5× 38 0.3× 54 0.5× 44 0.5× 28 657
Bradley Freilich United States 9 576 0.7× 655 0.8× 30 0.3× 88 0.8× 101 1.1× 14 828
Makoto Tanikawa Japan 20 981 1.1× 938 1.1× 39 0.3× 137 1.3× 39 0.4× 69 1.4k
S. Nishiguchi Japan 18 1.4k 1.6× 1.3k 1.5× 73 0.7× 292 2.7× 45 0.5× 35 1.9k

Countries citing papers authored by Stephen Pianko

Since Specialization
Citations

This map shows the geographic impact of Stephen Pianko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Pianko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Pianko more than expected).

Fields of papers citing papers by Stephen Pianko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Pianko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Pianko. The network helps show where Stephen Pianko may publish in the future.

Co-authorship network of co-authors of Stephen Pianko

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Pianko. A scholar is included among the top collaborators of Stephen Pianko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Pianko. Stephen Pianko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Serfaty, Lawrence, Stephen Pianko, Ziv Ben Ari, et al.. (2016). High Sustained Virologic Response (SVR) Rates in Patients with Chronic HCV GT1, 2 or 3 Infection Following 16 Weeks of MK-3682/Grazoprevir/MK-8408 Plus Ribavirin After Failure of 8 Weeks of Therapy (Part C of C-CREST-1 & 2). Hepatology. 64. 4 indexed citations
3.
Thompson, Alexander, Keyur Patel, Wan‐Long Chuang, et al.. (2011). Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3. Gut. 61(1). 128–134. 75 indexed citations
4.
Nelson, David R., Yves Benhamou, Wan‐Long Chuang, et al.. (2010). Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3. Gastroenterology. 139(4). 1267–1276.e4. 68 indexed citations
5.
Blombery, Piers, H. Miles Prince, Michele Levinson, et al.. (2010). Rituximab-Induced Immunodysregulatory Ileocolitis in a Patient With Follicular Lymphoma. Journal of Clinical Oncology. 29(5). e110–e112. 23 indexed citations
6.
7.
Zeuzem, Stefan, Eric M. Yoshida, Yves Benhamou, et al.. (2008). Albinterferon alfa‐2b dosed every two or four weeks in interferon‐naïve patients with genotype 1 chronic hepatitis C†‡. Hepatology. 48(2). 407–417. 64 indexed citations
8.
Patel, Keyur, Suzanne Norris, Lauralynn K. Lebeck, et al.. (2006). HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C. Hepatology. 43(2). 241–249. 34 indexed citations
9.
Desmond, Christopher, S. Roberts, F. J. Dudley, et al.. (2005). Sustained virological response rates and durability of the response to interferon‐based therapies in hepatitis C patients treated in the clinical setting. Journal of Viral Hepatitis. 13(5). 311–315. 51 indexed citations
10.
McHutchison, John G., Keyur Patel, Paul J. Pockros, et al.. (2005). A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients. Journal of Hepatology. 44(1). 88–96. 50 indexed citations
11.
Monto, Alexander, Keyur Patel, Alan Bostrom, et al.. (2004). Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology. 39(3). 826–834. 126 indexed citations
12.
Myers, Rob, Keyur Patel, Stephen Pianko, Thierry Poynard, & John G. McHutchison. (2003). The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C. Journal of Viral Hepatitis. 10(1). 16–22. 39 indexed citations
13.
Sievert, William, Lindsay Mollison, Stephen Pianko, et al.. (2003). Induction interferon and ribavirin for re‐treatment of chronic hepatitis C patients unresponsive to interferon alone. Alimentary Pharmacology & Therapeutics. 17(9). 1197–1204. 4 indexed citations
14.
Reynolds, Wanda F., Keyur Patel, Stephen Pianko, et al.. (2002). A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection. Genes and Immunity. 3(6). 345–349. 37 indexed citations
15.
Pianko, Stephen, Shane Patella, George Ostapowicz, Paul Desmond, & William Sievert. (2001). Fas‐mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection. Journal of Viral Hepatitis. 8(6). 406–413. 77 indexed citations
16.
Pianko, Stephen, Shane Patella, & William Sievert. (2000). Alcohol consumption induces hepatocyte apoptosis in patients with chronic hepatitis C infection. Journal of Gastroenterology and Hepatology. 15(7). 798–805. 25 indexed citations
17.
Pianko, Stephen. (2000). Retreatment of hepatitis C patients who do not respond to interferon: the search continues. The American Journal of Gastroenterology. 95(5). 1122–1124. 1 indexed citations
18.
McHutchison, John G., Gianluigi Giannelli, Lisa M. Nyberg, et al.. (1999). A Pilot Study of Daily Subcutaneous Interleukin-10 in Patients with Chronic Hepatitis C Infection. Journal of Interferon & Cytokine Research. 19(11). 1265–1270. 28 indexed citations
19.
Pianko, Stephen & John G. McHutchison. (1999). Chronic hepatitis B: new therapies on the horizon?. The Lancet. 354(9191). 1662–1663. 6 indexed citations
20.
Korman, M. G., et al.. (1997). Sucralfate as an Alternative to Bismuth in Quadruple Therapy for Helicobacter pylori Eradication. Helicobacter. 2(3). 140–143. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi‐Hao Yen Breakdown of academic impact, for papers by Eduardo B. Martins Breakdown of academic impact, for papers by Elisabetta Degasperi Breakdown of academic impact, for papers by Jaime Enríquez Breakdown of academic impact, for papers by Claudio Zavaglia Breakdown of academic impact, for papers by Franklin H. Herlong Breakdown of academic impact, for papers by Themistoklis Vassiliadis Breakdown of academic impact, for papers by Bradley Freilich Breakdown of academic impact, for papers by Makoto Tanikawa Breakdown of academic impact, for papers by S. Nishiguchi
Rankless by CCL
2026